Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA Vaccine against the JN.1 Variant
View ORCID ProfileNabin K. Shrestha, Patrick C. Burke, View ORCID ProfileAmy S. Nowacki, Steven M. Gordon
doi: https://doi.org/10.1101/2024.04.27.24306378
Nabin K. Shrestha
1Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA
Patrick C. Burke
2Infection Prevention, Cleveland Clinic, Cleveland, Ohio, USA
Amy S. Nowacki
3Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA
Steven M. Gordon
1Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted April 29, 2024.
Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA Vaccine against the JN.1 Variant
Nabin K. Shrestha, Patrick C. Burke, Amy S. Nowacki, Steven M. Gordon
medRxiv 2024.04.27.24306378; doi: https://doi.org/10.1101/2024.04.27.24306378
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (707)
- Anesthesia (199)
- Cardiovascular Medicine (2906)
- Dermatology (249)
- Emergency Medicine (436)
- Epidemiology (12674)
- Forensic Medicine (10)
- Gastroenterology (823)
- Genetic and Genomic Medicine (4532)
- Geriatric Medicine (411)
- Health Economics (723)
- Health Informatics (2895)
- Health Policy (1065)
- Hematology (382)
- HIV/AIDS (917)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4296)
- Nursing (233)
- Nutrition (631)
- Oncology (2249)
- Ophthalmology (639)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (275)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1192)
- Primary Care Research (491)
- Public and Global Health (6878)
- Radiology and Imaging (1515)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (481)
- Toxicology (60)
- Transplantation (208)
- Urology (178)